Schizophrenia biomarkers: Translating the descriptive into the diagnostic

Journal of Psychopharmacology

Volumn 29, Issue 2, 2015, Pages 138-143

  Pickard, Benjamin S ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

biomarker; epigenetics; inflammation; metabolism; metabolomics; methylomics; microarray; neurodevelopment; oxidative stress; Schizophrenia; transcriptomics

Indexed keywords

ALLANTOIN; BIOLOGICAL MARKER; CITRIC ACID; CLOZAPINE; CYCLOOXYGENASE 2; CYSTEINE; GAMMA INTERFERON; GLUTAMIC ACID; HALOPERIDOL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INOSITOL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROLINE; RISPERIDONE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ARTICLE; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MASS FRAGMENTOGRAPHY; METABOLOMICS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION; METABOLISM;

BIOLOGICAL MARKERS; HUMANS; SCHIZOPHRENIA;

EID: 84922229396     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114566631     Document Type: Article

References (45)

1. Aberg KA, Mcclay JL, Nerella S, et al. Mbd-Seq as a cost-effective approach for methylome-wide association studies: Demonstration in 1500 case-control samples. Epigenomics. 2013 ; 4: 605-621
2. Andreassen OA, Harbo HF, Wang Y, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry. 2014 ;:
3. Chen C, Cheng L, Grennan K, et al. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2012 ; 18: 1308-1314
4. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. The Lancet. 2013 ; 381: 1371-1379
5. Corvin AP. Two patients walk into a clinic. A genomics perspective on the future of schizophrenia. BMC Biol. 2012 ; 9: 77
6. De Jong S, Boks MP, Fuller TF, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One. 2012 ; 7: e39498
7. De Witte L, Tomasik J, Schwarz E, et al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 2014 ; 154: 23-29
8. Fischer K, Kettunen J, Wurtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17,345 persons. PLoS Med. 2014 ; 11: e1001606
9. Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013 ; 74: 400-409
10. Garcia-Bueno B, Bioque M, Mac-Dowell KS, et al. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull. 2013 ; 40: 376-387
11. Gardiner EJ, Cairns MJ, Liu B, et al. Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. J Psychiatr Res. 2013 ; 47: 425-437
12. Harris LW, Guest PC, Wayland MT, et al. Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology. 2013 ; 38: 752-766
13. Harris LW, Pietsch S, Cheng TM, et al. Comparison of peripheral and central schizophrenia biomarker profiles. PLoS One. 2012 ; 7: e46368
14. He Y, Yu Z, Giegling I, et al. Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 ; 2: e149
15. Hye A, Riddoch-Contreras J, Baird AL, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014 ; 10: 799-807
16. Kaddurah-Daouk R, Mcevoy J, Baillie R, et al. Impaired plasmalogens in patients with schizophrenia. Psychiatry Res. 2012 ; 198: 347-352
17. Kumarasinghe N, Tooney PA, Schall U. Finding the needle in the haystack: A review of microarray gene expression research into schizophrenia. Aust N Z J Psychiatry. 2012 ; 46: 598-610
18. Lee SH, Ripke S, Neale BM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide Snps. Nat Genet. 2013 ; 45: 984-994
19. McCarthy SE, Gillis J, Kramer M, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry. 2014 ; 19: 652-658
20. Mamdani F, Martin MV, Lencz T, et al. Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia. Dis Markers. 2013 ; 35: 11-21
21. Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014 ; 20: 415-418
22. Maschietto M, Silva AR, Puga RD, et al. Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls. Psychiatry Res. 2012 ; 200: 1018-1021
23. Melas PA, Rogdaki M, Osby U, et al. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 2012 ; 26: 2712-2718
24. Michel M, Schmidt MJ, Mirnics K. Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol. 2013 ; 72: 1277-1287
25. Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008 ; 82: 696-711
26. Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011 ; 70: 663-671
27. Mistry M, Gillis J, Pavlidis P. Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci. 2013 ; 14: 105
28. Nishioka M, Bundo M, Kasai K, et al. DNA methylation in schizophrenia: Progress and challenges of epigenetic studies. Genome Med. 2013 ; 4: 96
29. Nishioka M, Bundo M, Koike S, et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet. 2013 ; 58: 91-97
30. Oresic M, Tang J, Seppanen-Laakso T, et al. Metabolome in schizophrenia and other psychotic disorders: A general population-based study. Genome Med. 2011 ; 3: 19
31. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004 ; 351: 2817-2826
32. Perez-Santiago J, Diez-Alarcia R, Callado LF, et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res. 2013 ; 46: 1464-1474
33. Pickard B. Progress in defining the biological causes of schizophrenia. Expert Rev Mol Med. 2011 ; 13: e25
34. Ruderfer DM, Fanous AH, Ripke S, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014 ; 19: 1017-1024
35. Sainz J, Mata I, Barrera J, et al. Inflammatory and immune response genes have significantly altered expression in schizophrenia. Mol Psychiatry. 2013 ; 18: 1056-1057
36. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014 ; 511: 421-427
37. Schwarz E, Van Beveren NJ, Ramsey J, et al. Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophr Bull. 2014 ; 40: 787-795
38. Takahashi M, Hayashi H, Watanabe Y, et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res. 2010 ; 119: 210-218
39. Weickert CS, Weickert TW, Pillai A, et al. Biomarkers in schizophrenia: A brief conceptual consideration. Dis Markers. 2013 ; 35: 3-9
40. Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003 ; 100: 1896-1901
41. Wockner LF, Noble EP, Lawford BR, et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry. 2014 ; 4: e339
42. Xiao Y, Camarillo C, Ping Y, et al. The DNA Methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS One. 2014 ; 9: e95875
43. Xin Y, Chanrion B, O'Donnell AH, et al. Methylomedb: A database of DNA methylation profiles of the brain. Nucleic Acids Res. 2012 ; 40: D1245 - D1249
44. Xuan J, Pan G, Qiu Y, et al. Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2012 ; 10: 5433-5443
45. Yang J, Chen T, Sun L, et al. Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 ; 18: 67-78